NASDAQ: NGNE 31.15%
Neurogene Shares Rally on FDA Breakthrough Therapy Designation for Rett Syndrome Therapy
NASDAQ: BYND 32.83%
Expected US Company Earnings on Wednesday, February 25th, 2026
OTC: ACXIF 21.95%
Underperform Recommendation Issued On ACXIF By RBC Capital
NASDAQ: ENSC 73.31%
Expected US Company Earnings on Tuesday, November 11th, 2025
NASDAQ: DLLL 42.51%
US Companies Moving the Markets, Evening edition Fri, Feb 27, 2026 as of 4:00 pm ET
NASDAQ: AAOI 45.77%
Applied Optoelectronics (AAOI) Earnings Call
NASDAQ: NGNE 32.83%
NASDAQ: ACXIF 32.83%
NASDAQ: ENSC 32.83%
NASDAQ: DLLL 32.83%
